Amanda Brink, DNP, APRN, FNP-BC, AOCNP

home / authors / amanda-brink-dnp-aprn-fnp-bc-aocnp

Amanda Brink is a nurse practitioner at the University of Texas MD Anderson Cancer Center. When she is not tending to patients in the hospital or clinic, she finds great satisfaction in crafting content to enlighten the public and her fellow nurses about a range of health topics.

Articles

Opinion: CAR T-Cell Therapy as a Promising Avenue in Glioblastoma Treatment

April 24th 2024

Oncology nurses can educate their patients on the latest developments in CAR T-cell therapy for the treatment of glioblastoma.

Opinion: Osimertinib Plus Chemo May Enhance Outcomes in Metastatic EGFR-Mutated Lung Cancer

April 15th 2024

Oncology nurses play a vital role in informing patients about the importance of molecular testing and brain imaging in EGFR-mutated lung cancer.

Disease destroying human cell abstract illness concept illustration. | Image Credit: © picture-waterfall - stock.adobe.com

Opinion: Neoadjuvant Immunotherapy May Improve Outcomes in Sarcoma

March 27th 2024

Oncology nurses can assist in educating patients with sarcoma about clinical trial outcomes and the benefits of participating in trials.

Beyond the Scope: Improving Colorectal Cancer Screening With Stool DNA Testing

March 14th 2024

Oncology nurses can inform patients about the probability of identifying advanced neoplasia using stool-based screening tools.

Opinion: Tinengotinib Shows Promise for Cholangiocarcinoma After FGFR Inhibitor Treatment

February 27th 2024

Oncology nurses can advocate for patients with cholangiocarcinoma to participate in on-going clinical trials with tinengotinib.

KRAS G12C mutation in non-small cell lung cancer (NSCLC) - closeup view 3d illustration | Image Credit: © LASZLO - stock.adobe.com.

Opinion: KRAS Mutations Provide Prognostic Insights and Expand Treatment Options

February 21st 2024

Oncology nurses can assist patients in understanding the significance of KRAS mutation testing and its treatment implications.

Beautiful multi-colored beans in bowls and wooden spoons on a background of burlap | Image Credit: © mikhail_kayl - stock.adobe.com

Opinion: Beans, Microbes, and Cancer: Illuminating the Microbiome's Response to Dietary Intervention

January 30th 2024

Consuming navy beans daily as a dietary intervention may contribute to the health of the body's microbiome.

Opinion: ctHPVDNA Testing Could Improve Surveillance in Oropharyngeal Squamous Cell Carcinoma

January 18th 2024

Oncology nurses play a crucial role in educating patients regarding risks and benefits of circulating-tumor HPV DNA biomarker testing.

Opinion: Avasopasem—A Promising Approach to Enhance Efficacy and Minimize Toxicity in Pancreatic Cancer Radiation Therapy

January 3rd 2024

Oncology nurses can illuminate the potential of avasopasem to enhance pancreatic cancer outcomes and champion ongoing research.

Opinion: CAR T-Cell Therapy Remains a Promising Therapeutic Option Despite FDA Inquiry into Secondary Malignancies

December 5th 2023

Oncology nurses should be ready to offer informative guidance to patients and their families concerning the ongoing FDA inquiry and its potential impact.

Methylene Blue Has Potential to Transform Mucositis Management in Head and Neck Cancer

November 23rd 2023

Nurses can be empowered to advocate for methylene blue therapy as an effective oral mucositis pain relief treatment.

LINE-1-ORF1p Is a Promising Biomarker for Early Cancer Detection, But More Research Is Needed

November 22nd 2023

Oncology nurses can help patients understand the potential benefit of ORF1p testing for early cancer detection and its current limitations.

Opinion: For Those With Lynch Syndrome, Exercise May Be A Useful Defense Against Colorectal Cancer

October 24th 2023

A structured exercise program may aid in preventing colorectal cancer in patients with Lynch syndrome.

Mammogram © Tyler Olson - stockadobe.com

Opinion: Cancer Screenings, Although Not Perfect, Remain Valuable

October 18th 2023

Cancer screening tests may not extend life expectancy; however, they still are valuable for public health.

Opinion: The Media May Have Oversold AOH1996, City of Hope's Pioneering Cancer Drug

September 20th 2023

AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early research.

Opinion: Tumor-Treating Fields Hold Promise in Metastatic Non–Small Cell Lung Cancer

September 13th 2023

TTFields therapy, when given in addition to standard systemic therapy, improved overall survival in patients with metastatic non–small cell lung cancer.